ALXN - Alexion Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Alexion Pharmaceuticals's activity chart (see below) currently has 332 price targets and 251 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.62% with an average time for these price targets to be met of 705.26 days.

Most recent stock forecast was given by from OPPENHEIMER on 05-May-2021.

Best performing analysts who are covering ALXN - Alexion Pharmaceuticals:

Simos Simeonidis Anupam Rama Eric Schmidt Christopher James Steven Seedhouse

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jul-2017

$205

$22.5 (12.33%)

5 years 4 months 11 days ago
(05-May-2021)

3/5 (60%)

$35.09 (20.65%)

938

Hold Since 03-May-2021

$173

$-9.5 (-5.21%)

$156

5 years 4 months 13 days ago
(03-May-2021)

17/29 (58.62%)

$2.73 (1.60%)

650

Hold Since 04-Feb-2021

$190

$7.5 (4.11%)

$190

5 years 4 months 21 days ago
(26-Apr-2021)

11/14 (78.57%)

$23 (13.77%)

420

Buy Since 06-Sep-2019

$175

$-7.5 (-4.11%)

$165

5 years 7 months 12 days ago
(04-Feb-2021)

3/3 (100%)

$19.41 (12.48%)

397

Buy Since 17-Jul-2017

$166

$-16.5 (-9.04%)

$175

5 years 7 months 12 days ago
(04-Feb-2021)

32/33 (96.97%)

$10.41 (6.69%)

867

Show more analysts

Please expand the browser size to see the chart

What is ALXN (Alexion Pharmaceuticals) average time for price targets to be met?

On average it took 705 days for the stock forecasts to be reached, with an average price target met ratio of 86.62%.

Which analyst most recently updated their price target on ALXN (Alexion Pharmaceuticals)?

Which analyst has the most public recommendations on ALXN (Alexion Pharmaceuticals)?

has 0 price targets and 0 ratings on ALXN

Which analyst is the currently most bullish on ALXN (Alexion Pharmaceuticals)?

Jonathan Aschoff with the highest potential upside of $38.5

Which analyst is the currently most reserved on ALXN (Alexion Pharmaceuticals)?

Geoff Meacham with the lowest potential downside of -$72.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?